Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. [electronic resource]
Producer: 20110411Description: 687-93 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- BRCA1 Protein -- genetics
- Breast Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
- Paclitaxel -- administration & dosage
- Ribonucleoside Diphosphate Reductase
- Survival
- Time Factors
- Treatment Outcome
- Tumor Suppressor Proteins -- genetics
- Young Adult
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.